Safe your eye-sight and your money and read this information first:
A conventional laser therapy leads to a reduction in the drusen via a thermocoagulation of the tissue, but it also damages the photoreceptors in the radiation field and ultimately does not prevent the progression of the AMD. In addition, the breakdown and decline of drusen can sometimes also be observed in the natural course of the disease. Therefore, according to the recommendation of the professional societies, conventional laser therapy for dry AMD can not be recommended at present.
More recent micropulses and / or sub-threshold laser methods are offered as so-called “selective retinal therapy” (SRT) or as so-called nanosecond laser “2RT” from Ellex for the treatment of macular invertebrates. They are intended to exert the desired effect on the pigment epithelial cells without damaging the overlying photoreceptors. These procedures are currently in clinical trials for early and intermediate dry AMD (in the absence of geographic atrophy). So far there is no scientifically proven evidence to be able to conclusively assess the positive effect on the course of an AMD.
Currently, according to the recommendation of the professional societies, any retinal laser therapies for dry AMD should only be performed within clinical trials.
Send us a mail if you want to have a treatment with our Peptide-Bioregulators, the only existing safe treatment in the world.